Loading…
Interaction between baricity (glucose concentration) and other factors influencing intrathecal drug spread
The effects of intrathecal injection of 0.5% bupivacaine in solutions containing various concentrations of glucose have been studied in four groups of 20 patients. When solutions containing 0.8% glucose were injected at the L3–4 interspace the median maximum extent of block was higher, and the range...
Saved in:
Published in: | British journal of anaesthesia : BJA 1994-12, Vol.73 (6), p.744-746 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c504t-144a89a5bd280d2c33739daaf38e63ed540ab7585f7022ee1bcc37f20728413f3 |
---|---|
cites | |
container_end_page | 746 |
container_issue | 6 |
container_start_page | 744 |
container_title | British journal of anaesthesia : BJA |
container_volume | 73 |
creator | SANDERSON, P. READ, J. LITTLEWOOD, D.G. MCKEOWN, D. WILDSMITH, J.A.W. |
description | The effects of intrathecal injection of 0.5% bupivacaine in solutions containing various concentrations of glucose have been studied in four groups of 20 patients. When solutions containing 0.8% glucose were injected at the L3–4 interspace the median maximum extent of block was higher, and the range of blocks wider, with the 8% solution. All patients receiving 0.8% glucose had blocks between the T5 and T10 dermatomes, confirming previous work on the benefits of this concentration of glucose. In the two other groups 0.5% bupivacaine containing 0 or 0.8% glucose was injected at the L2–3 interspace. In both groups of patients a wider range of blocks, with a median maximum extent that was higher, was produced. These results demonstrate how glucose concentration may be used to influence the spread of intrathecal solutions and how other factors can obscure the effect of glucose concentration. |
doi_str_mv | 10.1093/bja/73.6.744 |
format | article |
fullrecord | <record><control><sourceid>istex_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_bja_73_6_744</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0007091217416436</els_id><sourcerecordid>ark_67375_HXZ_CXNQV5RZ_B</sourcerecordid><originalsourceid>FETCH-LOGICAL-c504t-144a89a5bd280d2c33739daaf38e63ed540ab7585f7022ee1bcc37f20728413f3</originalsourceid><addsrcrecordid>eNptkE1vEzEQhi0EKmnhxhXJBw4gsak_1vbusURAK1UgEKCqF2vWHqcO6W5kO5T-exwlyonTjPQ-M5p5CHnF2ZyzXp4PKzg3cq7npm2fkBlvDW-0MfwpmTHGTMN6Lp6T05xXjHEjenVCTkzXMa30jKyuxoIJXInTSAcsD4i1Qooulkf6drneuikjddPocCwJdtw7CqOnU7nDREMdnVKmcQzrLY4ujsva78A7dLCmPm2XNG8Sgn9BngVYZ3x5qGfk56ePPxaXzfXXz1eLi-vGKdaWhrctdD2owYuOeeGkNLL3AEF2qCV61TIYjOpUMEwIRD44J00QzIiu5TLIM_J-v9elKeeEwW5SvIf0aDmzO2O2GrNGWm2rsYq_3uOb7XCP_ggfFNX8zSGHXD8KCeqX-YhJKYTQrGLNHou54N9jDOm31UYaZS9vbu3i5su3X-r7rf1Qeb3nsar4EzHZ7GIViD4mdMX6Kf7_3n8MxZeY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Interaction between baricity (glucose concentration) and other factors influencing intrathecal drug spread</title><source>Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025</source><creator>SANDERSON, P. ; READ, J. ; LITTLEWOOD, D.G. ; MCKEOWN, D. ; WILDSMITH, J.A.W.</creator><creatorcontrib>SANDERSON, P. ; READ, J. ; LITTLEWOOD, D.G. ; MCKEOWN, D. ; WILDSMITH, J.A.W.</creatorcontrib><description>The effects of intrathecal injection of 0.5% bupivacaine in solutions containing various concentrations of glucose have been studied in four groups of 20 patients. When solutions containing 0.8% glucose were injected at the L3–4 interspace the median maximum extent of block was higher, and the range of blocks wider, with the 8% solution. All patients receiving 0.8% glucose had blocks between the T5 and T10 dermatomes, confirming previous work on the benefits of this concentration of glucose. In the two other groups 0.5% bupivacaine containing 0 or 0.8% glucose was injected at the L2–3 interspace. In both groups of patients a wider range of blocks, with a median maximum extent that was higher, was produced. These results demonstrate how glucose concentration may be used to influence the spread of intrathecal solutions and how other factors can obscure the effect of glucose concentration.</description><identifier>ISSN: 0007-0912</identifier><identifier>EISSN: 1471-6771</identifier><identifier>DOI: 10.1093/bja/73.6.744</identifier><identifier>PMID: 7880656</identifier><identifier>CODEN: BJANAD</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Aged ; Aged, 80 and over ; Anaesthetic techniques ; Anaesthetic techniques, subarachnoid ; Anaesthetics local ; Anaesthetics local, bupivacaine ; Anesthesia, Endotracheal ; Anesthetics. Neuromuscular blocking agents ; baricity ; Biological and medical sciences ; bupivacaine ; Bupivacaine - administration & dosage ; Bupivacaine - chemistry ; Bupivacaine - metabolism ; Bupivacaine - pharmacokinetics ; Dose-Response Relationship, Drug ; Drug Carriers ; Drug Interactions ; Female ; Glucose - administration & dosage ; Glucose - pharmacokinetics ; Humans ; Male ; Medical sciences ; Middle Aged ; Nerve Block ; Neuropharmacology ; Pharmacology. Drug treatments ; Physics ; Physics, baricity ; Spinal Puncture ; subarachnoid ; Time Factors</subject><ispartof>British journal of anaesthesia : BJA, 1994-12, Vol.73 (6), p.744-746</ispartof><rights>1994</rights><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c504t-144a89a5bd280d2c33739daaf38e63ed540ab7585f7022ee1bcc37f20728413f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3322260$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7880656$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SANDERSON, P.</creatorcontrib><creatorcontrib>READ, J.</creatorcontrib><creatorcontrib>LITTLEWOOD, D.G.</creatorcontrib><creatorcontrib>MCKEOWN, D.</creatorcontrib><creatorcontrib>WILDSMITH, J.A.W.</creatorcontrib><title>Interaction between baricity (glucose concentration) and other factors influencing intrathecal drug spread</title><title>British journal of anaesthesia : BJA</title><addtitle>Br J Anaesth</addtitle><description>The effects of intrathecal injection of 0.5% bupivacaine in solutions containing various concentrations of glucose have been studied in four groups of 20 patients. When solutions containing 0.8% glucose were injected at the L3–4 interspace the median maximum extent of block was higher, and the range of blocks wider, with the 8% solution. All patients receiving 0.8% glucose had blocks between the T5 and T10 dermatomes, confirming previous work on the benefits of this concentration of glucose. In the two other groups 0.5% bupivacaine containing 0 or 0.8% glucose was injected at the L2–3 interspace. In both groups of patients a wider range of blocks, with a median maximum extent that was higher, was produced. These results demonstrate how glucose concentration may be used to influence the spread of intrathecal solutions and how other factors can obscure the effect of glucose concentration.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anaesthetic techniques</subject><subject>Anaesthetic techniques, subarachnoid</subject><subject>Anaesthetics local</subject><subject>Anaesthetics local, bupivacaine</subject><subject>Anesthesia, Endotracheal</subject><subject>Anesthetics. Neuromuscular blocking agents</subject><subject>baricity</subject><subject>Biological and medical sciences</subject><subject>bupivacaine</subject><subject>Bupivacaine - administration & dosage</subject><subject>Bupivacaine - chemistry</subject><subject>Bupivacaine - metabolism</subject><subject>Bupivacaine - pharmacokinetics</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Carriers</subject><subject>Drug Interactions</subject><subject>Female</subject><subject>Glucose - administration & dosage</subject><subject>Glucose - pharmacokinetics</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nerve Block</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Physics</subject><subject>Physics, baricity</subject><subject>Spinal Puncture</subject><subject>subarachnoid</subject><subject>Time Factors</subject><issn>0007-0912</issn><issn>1471-6771</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><recordid>eNptkE1vEzEQhi0EKmnhxhXJBw4gsak_1vbusURAK1UgEKCqF2vWHqcO6W5kO5T-exwlyonTjPQ-M5p5CHnF2ZyzXp4PKzg3cq7npm2fkBlvDW-0MfwpmTHGTMN6Lp6T05xXjHEjenVCTkzXMa30jKyuxoIJXInTSAcsD4i1Qooulkf6drneuikjddPocCwJdtw7CqOnU7nDREMdnVKmcQzrLY4ujsva78A7dLCmPm2XNG8Sgn9BngVYZ3x5qGfk56ePPxaXzfXXz1eLi-vGKdaWhrctdD2owYuOeeGkNLL3AEF2qCV61TIYjOpUMEwIRD44J00QzIiu5TLIM_J-v9elKeeEwW5SvIf0aDmzO2O2GrNGWm2rsYq_3uOb7XCP_ggfFNX8zSGHXD8KCeqX-YhJKYTQrGLNHou54N9jDOm31UYaZS9vbu3i5su3X-r7rf1Qeb3nsar4EzHZ7GIViD4mdMX6Kf7_3n8MxZeY</recordid><startdate>19941201</startdate><enddate>19941201</enddate><creator>SANDERSON, P.</creator><creator>READ, J.</creator><creator>LITTLEWOOD, D.G.</creator><creator>MCKEOWN, D.</creator><creator>WILDSMITH, J.A.W.</creator><general>Elsevier Ltd</general><general>Oxford University Press</general><scope>6I.</scope><scope>AAFTH</scope><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19941201</creationdate><title>Interaction between baricity (glucose concentration) and other factors influencing intrathecal drug spread</title><author>SANDERSON, P. ; READ, J. ; LITTLEWOOD, D.G. ; MCKEOWN, D. ; WILDSMITH, J.A.W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c504t-144a89a5bd280d2c33739daaf38e63ed540ab7585f7022ee1bcc37f20728413f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anaesthetic techniques</topic><topic>Anaesthetic techniques, subarachnoid</topic><topic>Anaesthetics local</topic><topic>Anaesthetics local, bupivacaine</topic><topic>Anesthesia, Endotracheal</topic><topic>Anesthetics. Neuromuscular blocking agents</topic><topic>baricity</topic><topic>Biological and medical sciences</topic><topic>bupivacaine</topic><topic>Bupivacaine - administration & dosage</topic><topic>Bupivacaine - chemistry</topic><topic>Bupivacaine - metabolism</topic><topic>Bupivacaine - pharmacokinetics</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Carriers</topic><topic>Drug Interactions</topic><topic>Female</topic><topic>Glucose - administration & dosage</topic><topic>Glucose - pharmacokinetics</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nerve Block</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Physics</topic><topic>Physics, baricity</topic><topic>Spinal Puncture</topic><topic>subarachnoid</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SANDERSON, P.</creatorcontrib><creatorcontrib>READ, J.</creatorcontrib><creatorcontrib>LITTLEWOOD, D.G.</creatorcontrib><creatorcontrib>MCKEOWN, D.</creatorcontrib><creatorcontrib>WILDSMITH, J.A.W.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>British journal of anaesthesia : BJA</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SANDERSON, P.</au><au>READ, J.</au><au>LITTLEWOOD, D.G.</au><au>MCKEOWN, D.</au><au>WILDSMITH, J.A.W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interaction between baricity (glucose concentration) and other factors influencing intrathecal drug spread</atitle><jtitle>British journal of anaesthesia : BJA</jtitle><addtitle>Br J Anaesth</addtitle><date>1994-12-01</date><risdate>1994</risdate><volume>73</volume><issue>6</issue><spage>744</spage><epage>746</epage><pages>744-746</pages><issn>0007-0912</issn><eissn>1471-6771</eissn><coden>BJANAD</coden><abstract>The effects of intrathecal injection of 0.5% bupivacaine in solutions containing various concentrations of glucose have been studied in four groups of 20 patients. When solutions containing 0.8% glucose were injected at the L3–4 interspace the median maximum extent of block was higher, and the range of blocks wider, with the 8% solution. All patients receiving 0.8% glucose had blocks between the T5 and T10 dermatomes, confirming previous work on the benefits of this concentration of glucose. In the two other groups 0.5% bupivacaine containing 0 or 0.8% glucose was injected at the L2–3 interspace. In both groups of patients a wider range of blocks, with a median maximum extent that was higher, was produced. These results demonstrate how glucose concentration may be used to influence the spread of intrathecal solutions and how other factors can obscure the effect of glucose concentration.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>7880656</pmid><doi>10.1093/bja/73.6.744</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-0912 |
ispartof | British journal of anaesthesia : BJA, 1994-12, Vol.73 (6), p.744-746 |
issn | 0007-0912 1471-6771 |
language | eng |
recordid | cdi_crossref_primary_10_1093_bja_73_6_744 |
source | Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025 |
subjects | Aged Aged, 80 and over Anaesthetic techniques Anaesthetic techniques, subarachnoid Anaesthetics local Anaesthetics local, bupivacaine Anesthesia, Endotracheal Anesthetics. Neuromuscular blocking agents baricity Biological and medical sciences bupivacaine Bupivacaine - administration & dosage Bupivacaine - chemistry Bupivacaine - metabolism Bupivacaine - pharmacokinetics Dose-Response Relationship, Drug Drug Carriers Drug Interactions Female Glucose - administration & dosage Glucose - pharmacokinetics Humans Male Medical sciences Middle Aged Nerve Block Neuropharmacology Pharmacology. Drug treatments Physics Physics, baricity Spinal Puncture subarachnoid Time Factors |
title | Interaction between baricity (glucose concentration) and other factors influencing intrathecal drug spread |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T16%3A59%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-istex_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interaction%20between%20baricity%20(glucose%20concentration)%20and%20other%20factors%20influencing%20intrathecal%20drug%20spread&rft.jtitle=British%20journal%20of%20anaesthesia%20:%20BJA&rft.au=SANDERSON,%20P.&rft.date=1994-12-01&rft.volume=73&rft.issue=6&rft.spage=744&rft.epage=746&rft.pages=744-746&rft.issn=0007-0912&rft.eissn=1471-6771&rft.coden=BJANAD&rft_id=info:doi/10.1093/bja/73.6.744&rft_dat=%3Cistex_cross%3Eark_67375_HXZ_CXNQV5RZ_B%3C/istex_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c504t-144a89a5bd280d2c33739daaf38e63ed540ab7585f7022ee1bcc37f20728413f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/7880656&rfr_iscdi=true |